These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34820393)

  • 21. The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial.
    Dastan F; Jamaati H; Barati S; Varmazyar S; Yousefian S; Niknami E; Tabarsi P
    Front Pharmacol; 2023; 14():1265541. PubMed ID: 37927607
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis.
    Zhang J; Fan X; Zhang X; Jiang F; Wu Y; Yang B; Li X; Liu D
    Front Pharmacol; 2023; 14():1293331. PubMed ID: 38074144
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study.
    Lakatos B; Szabó BG; Bobek I; Kiss-Dala N; Gáspár Z; Riczu A; Petrik B; Farkas BF; Sebestyén G; Gopcsa L; Bekő G; Sinkó J; Reményi P; Szlávik J; Mathiász D; Vályi-Nagy I
    Int J Infect Dis; 2022 Dec; 125():233-240. PubMed ID: 36328291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tocilizumab Versus Baricitinib for the Treatment of COVID-19 in Patients With Obesity.
    Troyer BS; Kovacic Scherrer N; Garavaglia J
    J Pharm Pract; 2024 Jun; 37(3):632-636. PubMed ID: 36803310
    [No Abstract]   [Full Text] [Related]  

  • 26. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
    Wolfe CR; Tomashek KM; Patterson TF; Gomez CA; Marconi VC; Jain MK; Yang OO; Paules CI; Palacios GMR; Grossberg R; Harkins MS; Mularski RA; Erdmann N; Sandkovsky U; Almasri E; Pineda JR; Dretler AW; de Castilla DL; Branche AR; Park PK; Mehta AK; Short WR; McLellan SLF; Kline S; Iovine NM; El Sahly HM; Doernberg SB; Oh MD; Huprikar N; Hohmann E; Kelley CF; Holodniy M; Kim ES; Sweeney DA; Finberg RW; Grimes KA; Maves RC; Ko ER; Engemann JJ; Taylor BS; Ponce PO; Larson L; Melendez DP; Seibert AM; Rouphael NG; Strebe J; Clark JL; Julian KG; de Leon AP; Cardoso A; de Bono S; Atmar RL; Ganesan A; Ferreira JL; Green M; Makowski M; Bonnett T; Beresnev T; Ghazaryan V; Dempsey W; Nayak SU; Dodd LE; Beigel JH; Kalil AC;
    Lancet Respir Med; 2022 Sep; 10(9):888-899. PubMed ID: 35617986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19.
    Skarbinski J; Liu L; Hong V; Amsden LB; Fireman BH; Yau VM; Incerti D; Qian L; Fischer H; Ackerson BK; Shaw SF; Tartof SY
    BMJ Open; 2022 Oct; 12(10):e060358. PubMed ID: 36316080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
    Kalil AC; Patterson TF; Mehta AK; Tomashek KM; Wolfe CR; Ghazaryan V; Marconi VC; Ruiz-Palacios GM; Hsieh L; Kline S; Tapson V; Iovine NM; Jain MK; Sweeney DA; El Sahly HM; Branche AR; Regalado Pineda J; Lye DC; Sandkovsky U; Luetkemeyer AF; Cohen SH; Finberg RW; Jackson PEH; Taiwo B; Paules CI; Arguinchona H; Erdmann N; Ahuja N; Frank M; Oh MD; Kim ES; Tan SY; Mularski RA; Nielsen H; Ponce PO; Taylor BS; Larson L; Rouphael NG; Saklawi Y; Cantos VD; Ko ER; Engemann JJ; Amin AN; Watanabe M; Billings J; Elie MC; Davey RT; Burgess TH; Ferreira J; Green M; Makowski M; Cardoso A; de Bono S; Bonnett T; Proschan M; Deye GA; Dempsey W; Nayak SU; Dodd LE; Beigel JH;
    N Engl J Med; 2021 Mar; 384(9):795-807. PubMed ID: 33306283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.
    Rodriguez-Garcia JL; Sanchez-Nievas G; Arevalo-Serrano J; Garcia-Gomez C; Jimenez-Vizuete JM; Martinez-Alfaro E
    Rheumatology (Oxford); 2021 Jan; 60(1):399-407. PubMed ID: 33020836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19.
    García-García JA; Pérez-Quintana M; Ramos-Giráldez C; Cebrián-González I; Martín-Ponce ML; Del Valle-Villagrán J; Navarro-Puerto MA; Sánchez-Villegas J; Gómez-Herreros R; Manoja-Bustos I; León-Martí D; Serrano-Rodríguez L; de Miguel-Albarreal A; Velasco-Romero MJ; Mula-Falcón F; Fernández-Pérez P; Melguizo-Moya I; Pérez-Quintana MJ; Romero-Molina G; Vergara-López S; Marenco-de la Fuente JL; Marín-Martín J; Mira-Escarti JA
    J Clin Med; 2021 Sep; 10(17):. PubMed ID: 34501467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.
    Paules CI; Wang J; Tomashek KM; Bonnett T; Singh K; Marconi VC; Davey RT; Lye DC; Dodd LE; Yang OO; Benson CA; Deye GA; Doernberg SB; Hynes NA; Grossberg R; Wolfe CR; Nayak SU; Short WR; Voell J; Potter GE; Rapaka RR
    Ann Intern Med; 2024 Mar; 177(3):343-352. PubMed ID: 38408357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center.
    Martínez-Guerra BA; de-León-Cividanes NA; Tamez-Torres KM; Román-Montes CM; Rajme-López S; Ortiz-Brizuela E; Aguilar-Salinas CA; Sierra-Madero J; Sifuentes-Osornio J; Ponce-de-León A; González-Lara MF
    Rev Invest Clin; 2022 Jan; 74(1):40-50. PubMed ID: 34618802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial.
    Hall FC; Cheriyan J; Cope AP; Galloway J; Wilkinson I; Bond S; Norton S; Banham-Hall E; Bayes H; Kostapanos M; Nodale M; Petchey WG; Sheeran T; Underwood J; Jayne DR;
    Lancet Respir Med; 2023 Dec; 11(12):1064-1074. PubMed ID: 37977159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
    Trøseid M; Arribas JR; Assoumou L; Holten AR; Poissy J; Terzić V; Mazzaferri F; Baño JR; Eustace J; Hites M; Joannidis M; Paiva JA; Reuter J; Püntmann I; Patrick-Brown TDJH; Westerheim E; Nezvalova-Henriksen K; Beniguel L; Dahl TB; Bouscambert M; Halanova M; Péterfi Z; Tsiodras S; Rezek M; Briel M; Ünal S; Schlegel M; Ader F; Lacombe K; Amdal CD; Rodrigues S; Tonby K; Gaudet A; Heggelund L; Mootien J; Johannessen A; Møller JH; Pollan BD; Tveita AA; Kildal AB; Richard JC; Dalgard O; Simensen VC; Baldé A; de Gastines L; Del Álamo M; Aydin B; Lund-Johansen F; Trabaud MA; Diallo A; Halvorsen B; Røttingen JA; Tacconelli E; Yazdanpanah Y; Olsen IC; Costagliola D;
    Crit Care; 2023 Jan; 27(1):9. PubMed ID: 36627655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study.
    Kojima Y; Nakakubo S; Takei N; Kamada K; Yamashita Y; Nakamura J; Matsumoto M; Horii H; Sato K; Shima H; Suzuki M; Konno S
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454352
    [No Abstract]   [Full Text] [Related]  

  • 36. Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants.
    Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Read SH; Lee E; Der-Torossian C; Gupta R; Berry M; Hollemeersch S; Kalil AC
    Open Forum Infect Dis; 2023 Oct; 10(10):ofad482. PubMed ID: 37869410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.
    Abizanda P; Calbo Mayo JM; Mas Romero M; Cortés Zamora EB; Tabernero Sahuquillo MT; Romero Rizos L; Sánchez-Jurado PM; Sánchez-Nievas G; Campayo Escolano C; Ochoa Serrano A; Sánchez-Flor Alfaro V; López Bru R; Gómez Ballesteros C; Caldevilla Bernardo D; Callejas González FJ; Andrés-Pretel F; Lauschke VM; Stebbing J
    J Am Geriatr Soc; 2021 Oct; 69(10):2752-2758. PubMed ID: 34235720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 blocking agents for treating COVID-19: a living systematic review.
    Ghosn L; Chaimani A; Evrenoglou T; Davidson M; Graña C; Schmucker C; Bollig C; Henschke N; Sguassero Y; Nejstgaard CH; Menon S; Nguyen TV; Ferrand G; Kapp P; Riveros C; Ávila C; Devane D; Meerpohl JJ; Rada G; Hróbjartsson A; Grasselli G; Tovey D; Ravaud P; Boutron I
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013881. PubMed ID: 33734435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tocilizumab administration for the treatment of hospitalized patients with COVID-19: A systematic review and meta-analysis.
    Kyriakopoulos C; Ntritsos G; Gogali A; Milionis H; Evangelou E; Kostikas K
    Respirology; 2021 Nov; 26(11):1027-1040. PubMed ID: 34605114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.